NewsBenzingaLyft、カリフォルニア州と2億7,250万ドルで和解へ 裁判所の承認が条件 2025年第4四半期に2億1,000万ドルの引当金を計上 2026年第3四半期の総取扱高、調整後EBITDA、調整後EBITDAマージンに変更はないと確認 Lyft、カリフォルニア州と2億7,250万ドルで和解へ 裁判所の承認が条件 2025年第4四半期に2億1,000万ドルの引当金を計上 2026年第3四半期の総取扱高、調整後EBITDA、調整後EBITDAマージンに変更はないと確認 Benzinga 2026.10.01 10:21 (GMT+0) Open on Benzinga Other news Anixa Biosciences Announces Second Patient Has Been Treated In Fifth Cohort Of Its Ongoing Phase 1, Dose-Escalating, Clinical Trial Evaluating FSHR-Targeted CAR-T Therapy For Recurrent Ovarian Cancer Wells Fargo Maintains Overweight on Microsoft, Raises Price Target to $725 Argus Research Upgrades Regeneron Pharmaceuticals to Buy, Announces $850 Price Target KULR Technology Group Receives $1M Orders For Its Battery Systems To Support U.S. Department Of War's Drone Dominance Program RenovoRx Announces Publication Of Peer-Reviewed Case Series In Case Reports In Oncology From Researchers At Hackensack Meridian Health’s Jersey Shore University Medical Center Wells Fargo Maintains Overweight on Synopsys, Raises Price Target to $540
Anixa Biosciences Announces Second Patient Has Been Treated In Fifth Cohort Of Its Ongoing Phase 1, Dose-Escalating, Clinical Trial Evaluating FSHR-Targeted CAR-T Therapy For Recurrent Ovarian Cancer
KULR Technology Group Receives $1M Orders For Its Battery Systems To Support U.S. Department Of War's Drone Dominance Program
RenovoRx Announces Publication Of Peer-Reviewed Case Series In Case Reports In Oncology From Researchers At Hackensack Meridian Health’s Jersey Shore University Medical Center
